How much is Odyssey Therapeutics worth in 2026?

Odyssey Therapeutics has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Odyssey Therapeutics raised?

Odyssey Therapeutics has raised $716.2M in total funding across 1 funding rounds.

Odyssey Therapeutics

BiotechnologyWebsite

Odyssey Therapeutics valuation and funding history | Last updated: September 10, 2025 | 1 funding rounds

Current Valuation

N/A

As of September 10, 2025

Total Funding Raised

$716.2M

Across 1 round

Last Round

Later Stage VC

$213.0M

Last Funding

Sep 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 13, 2022	Early Stage VC (Series B)	$168.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Odyssey Therapeutics is currently valued at N/A as of September 10, 2025. The company has raised a total of $716.2M in funding across 1 funding round.

Track Odyssey Therapeutics Valuation Updates

Get notified when Odyssey Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Odyssey Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Odyssey Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Odyssey Therapeutics Worth in 2026?

Odyssey Therapeutics is a leading private company in the Biotechnology sector. Track Odyssey Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Odyssey Therapeutics Valuation is Determined

Private company valuations like Odyssey Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.